Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Pharmaceutically acceptable salt as renal outer medullary potassium channel inhibitor

Pharmaceutically acceptable salt as renal outer medullary potassium channel inhibitor

US Patent 11059810 · Granted Jul 13, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Covalent inhibitors of KRAS G12C2025
Substituted quinazoline compounds and methods of use thereof2025
Crystal form of pyridopyrimidine derivative and preparation method thereof2025
Crystal form of pyridopyrimidine derivative and preparation method thereof2025
Substituted piperazines as inhibitors of KRAS G12C2025
Tricyclic pyridones and pyrimidones2024
Thermoplastic elastomer composition2024
Heterocyclic spiro compounds and methods of use thereof for the treatment of can2024
Chimeric receptors to DLL3 and methods of use thereof2024
Methods and compositions for modulating splicing2024
Substituted quinazolines as inhibitors of KRAS G12C2024
Tricyclic pyridones and pyrimidones2023